Macrophages in immunoregulation and therapeutics

S Chen, AFUH Saeed, Q Liu, Q Jiang, H Xu… - … and Targeted Therapy, 2023 - nature.com
Macrophages exist in various tissues, several body cavities, and around mucosal surfaces
and are a vital part of the innate immune system for host defense against many pathogens …

Lipid droplets, the central hub integrating cell metabolism and the immune system

W Zhang, L Xu, L Zhu, Y Liu, S Yang… - Frontiers in Physiology, 2021 - frontiersin.org
Lipid droplets (LDs) are commonly found in various biological cells and are organelles
related to cell metabolism. LDs, the number and size of which are heterogeneous across cell …

Photothermal therapy of tuberculosis using targeting pre-activated macrophage membrane-coated nanoparticles

B Li, W Wang, L Zhao, Y Wu, X Li, D Yan, Q Gao… - Nature …, 2024 - nature.com
Conventional antibiotics used for treating tuberculosis (TB) suffer from drug resistance and
multiple complications. Here we propose a lesion–pathogen dual-targeting strategy for the …

Antituberculosis targeted drug delivery as a potential future treatment approach

MKN Mazlan, MHD Mohd Tazizi, R Ahmad, MAA Noh… - Antibiotics, 2021 - mdpi.com
Mycobacterium tuberculosis (Mtb) is the microorganism that causes tuberculosis. This
infectious disease has been around for centuries, with the earliest record of Mtb around …

Between inflammation and autophagy: the role of leptin-adiponectin axis in cardiac remodeling

L Kamareddine, CM Ghantous, S Allouch… - Journal of …, 2021 - Taylor & Francis
Cardiac remodeling is the process by which the heart adapts to stressful stimuli, such as
hypertension and ischemia/reperfusion; it ultimately leads to heart failure upon long-term …

Nanosized Drug Delivery Systems to Fight Tuberculosis

T Bourguignon, JA Godinez-Leon, R Gref - Pharmaceutics, 2023 - mdpi.com
Tuberculosis (TB) is currently the second deadliest infectious disease. Existing
antitubercular therapies are long, complex, and have severe side effects that result in low …

Harnessing Host-Pathogen Interactions for Innovative Drug Discovery and Host-Directed Therapeutics to tackle tuberculosis.

S Saini, A Gangwar, R Sharma - Microbiological research, 2023 - Elsevier
Tuberculosis (TB) is a highly contagious bacterial infection caused by Mycobacterium
tuberculosis (Mtb), which has been ranked as the second leading cause of death worldwide …

Epigenetic orchestration of host immune defences by Mycobacterium tuberculosis

S Sengupta, KP Pattanaik, S Mishra… - Microbiological research, 2023 - Elsevier
Being among the top 10 causes of adult deaths, tuberculosis (TB) disease is considered a
major global public health concern to address. The human tuberculosis pathogen …

Autophagy and host defense in nontuberculous mycobacterial infection

P Silwal, IS Kim, EK Jo - Frontiers in immunology, 2021 - frontiersin.org
Autophagy is critically involved in host defense pathways through targeting and elimination
of numerous pathogens via autophagic machinery. Nontuberculous mycobacteria (NTMs) …

Preclinical evaluation of TB/FLU-04L—An intranasal influenza vector-based boost vaccine against tuberculosis

AP Shurygina, N Zabolotnykh, T Vinogradova… - International journal of …, 2023 - mdpi.com
Tuberculosis is a major global threat to human health. Since the widely used BCG vaccine is
poorly effective in adults, there is a demand for the development of a new type of boost …